Rampart Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Rampart Investment Management's REGN Position: Q4 2020 in Review
Rampart Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2020, closing a stake of 664 shares — an estimated $372K sold.
Rampart Investment Management first reported a position in REGN in Q3 2016 and held it in 17 quarters. The position peaked at $1.27M in Q2 2020. 904 funds tracked by Wall St. Rank hold REGN as of Q4 2020.
- Rampart Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Rampart Investment Management sold 664 Regeneron Pharmaceuticals shares in Q4 2020, an estimated $372K.
- Rampart Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2016 and held it in 17 quarters.
- Rampart Investment Management's Regeneron Pharmaceuticals position peaked at $1.27M in Q2 2020.
- 904 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2020.
Based on Rampart Investment Management's 13F filing for Q4 2020.